Skip to main content

Novartis and the University of Oxford's Big Data Institute are to establish a world-leading research alliance using artificial intelligence to understand complex diseases and improve drug development. For the entire press release please see here.

Related News

Professor Charlotte Deane elected Fellow of the Royal Society

Professor Charlotte Deane MBE, Professor of Structural Bioinformatics in Oxford’s Department of Statistics, has today been announced among the new Fellows of the Royal Society.

OpenBind releases first open dataset and AI model for drug discovery

The OpenBind consortium’s first release of experimental data marks a milestone in efforts to improve how artificial intelligence (AI) is used in drug discovery.

Oxford statisticians take part in PKU–Oxford conference on quantitative finance and data science

Researchers from the University of Oxford’s Department of Statistics were among those taking part in a joint conference with Peking University in April, bringing together academics working across quantitative finance, data science and related areas.